Suvorexant
| Use attributes for filter ! | |
| Molar mass | 450. 92 g/mol |
|---|---|
| Formula | C23H23ClN6O2 |
| Other names | MK-4305 |
| Trade name | Belsomra |
| Elimination half-life | ~12 hours |
| Metabolism | CYP3A |
| CYP2C19 | |
| Music groups | Ramelteon |
| Eszopiclone | |
| Zolpidem | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 2951261 |
About Suvorexant
Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia. It is effective for insomnia, at least for four weeks and as compared to a placebo. Suvorexant is a selective, dual orexin receptor antagonist made by Merck & Co.